National Institute for the Empowerment of Persons with Intellectual Disabilities (NIEPID), Ministry of Social Justice & Empowerment, Govt. of India
A 90-day prospective cohort study with 60 children (mental age 2–6 years) clinically diagnosed with mild to moderate ASD, ID, or DD.
Participants were divided into:
Experimental group (n=30): Received standard therapy + CognitiveBotics platform
Control group (n=30): Received only standard therapy
Primary tools used:
Developmental Screening Test (DST)
Vineland Social Maturity Scale (VSMS)
CognitiveBotics Checklist (CBT Checklist
Key Findings
Statistically significant improvements were observed in the experimental group:
Developmental Age: +18.93% (p = 0.00003)
Developmental Quotient: +11.23% (p = 0.00006)
Social Age: +12.55% (p = 0.000009)
Social Quotient: +6.39% (p = 0.000014)
Independent task completion increased by 59.56%
The control group showed minor gains in developmental age, and a decline in social quotient.
Status: Completed at NIEPID, 2025